resveratrol has been researched along with Insulin Resistance in 185 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (4.86) | 29.6817 |
| 2010's | 128 (69.19) | 24.3611 |
| 2020's | 48 (25.95) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, X; Ma, H; Shu, L; Song, G; Wang, C | 1 |
| Chen, Z; Guan, MX; Hong, S; Lin, C; Lou, Y; Shi, X; Wang, C; Xi, Y; Yang, X; Zhao, M; Zhao, X | 1 |
| Abdelhaleem, IA; Aboalfetoh, AY; Adayel, HM; Asla, MM; Brakat, AM; Rizk, MA | 1 |
| Khan, DA; Mahjabeen, W; Mirza, SA | 1 |
| Rabbani, N; Thornalley, PJ | 1 |
| Chan, KLA; Poonprasartporn, A | 1 |
| Bao, C; Feng, J; Tan, Y; Xiao, Y | 1 |
| Karimi, A; Mobasseri, M; Naeini, F; Najafipour, F; Tutunchi, H; Vajdi, M | 1 |
| Barber, TM; Kabisch, S; Pfeiffer, AFH; Randeva, HS; Weickert, MO | 1 |
| Ma, N; Zhang, Y | 1 |
| García-Martínez, BI; Mendoza-Núñez, VM; Pedraza-Chaverri, J; Ruiz-Ramos, M; Santiago-Osorio, E | 1 |
| Chen, J; Ge, A; Ge, J; Wang, S; Xu, H; Yang, K; Yuan, X; Zeng, L; Zhang, T | 1 |
| Abed, A; Abu Dayyih, W; Abumansour, H; Aburumman, A; Daoud, E; Hailat, M; Hamad, M; Majeed, B; Majeed, JM; Saadh, MJ; Tamimi, LN; Zakaraya, Z | 1 |
| Li, Z; Mei, J; Wang, Y; Wu, X; Yang, L; Zheng, G | 1 |
| Li, Z; Mei, J; Wang, Y; Yang, L; Zheng, G | 1 |
| Liu, C; Pan, X; Song, G; Wang, C; Wang, X; Zhang, X; Zhang, Z; Zhao, M | 1 |
| Frendo-Cumbo, S; MacPherson, REK; Yang, AJT | 1 |
| Bezerra Pontes, EO; Carneiro, EM; Coelho de Souza, AN; D Avila, LSP; de Abreu, ES; de Carvalho, DP; de Oliveira, AC; de Oliveira, KA; Leal Cardoso, JH; Nascimento, JF; Rickli, S; Silveira, LR; Torres Leal, FL; Vasconcelos, RP | 1 |
| Dong, L; Ma, HJ; Song, GY; Xing, HY; Zhang, YJ; Zhao, H; Zhen, YF | 1 |
| Chiang, BH; Kang, BB | 1 |
| Gong, L; Guo, S; Zou, Z | 1 |
| Birringer, M; Bracher, F; Danylec, N; Günther, I; Kulling, SE; Lüersen, K; Mack, CI; Pallauf, K; Rimbach, G; Soukup, ST; Weinert, CH | 1 |
| Den Hartogh, DJ; Giacca, A; Tsiani, E; Vlavcheski, F | 2 |
| Chen, K; Lu, C; Shu, L; Song, G; Wang, C; Xing, H; Zhao, H | 1 |
| Bagul, PK; Banerjee, SK; Rai, RC | 1 |
| Chen, F; Hu, X; Ke, W; Li, D; Wang, J; Wang, P | 1 |
| Hsu, MH; Huang, LT; Lin, IC; Sheen, JM; Tain, YL; Tiao, MM; Yu, HR | 1 |
| Fan, YJ; Zhao, YH | 1 |
| Bergman, M; de Ligt, M; Essers, H; Fuentes, RM; Havekes, B; Moonen-Kornips, E; Schrauwen, P; Schrauwen-Hinderling, VB | 1 |
| Hou, G; Huang, W; Ma, H; Shu, L; Song, G; Zhao, H | 1 |
| Gliemann, L | 1 |
| Zemel, MB | 1 |
| Breen, DM; Dalvi, PS; Dolinsky, VW; Giacca, A; Gonzalez Medina, M; Guo, J; Heximer, SP; McBurney, MW; McCole, DF; Mori, Y; Pereira, TJ; Tsiani, EL; Zhang, H | 1 |
| Howe, PR; Thaung Zaw, JJ; Wong, RH | 1 |
| Kitada, M; Koya, D; Monno, I; Ogura, Y | 1 |
| Gmoshinski, IV; Mzhelskaya, KV; Riger, NА; Shipelin, VА; Shumakova, АА; Timonin, АN; Trusov, NV; Аpryatin, SА | 1 |
| Askari, G; Ghavami, A; Mohammadi, H; Rafiee, S; Sadeghi, E; Safari, Z | 1 |
| de Ligt, M; Hesselink, MKC; Hoeks, J; Moonen-Kornips, E; Schaart, G; Schrauwen, P; Timmers, S; van Polanen, N; Zacharewicz, E | 1 |
| Delpino, FM; Figueiredo, LM | 1 |
| Eseberri, I; Lasa, A; Laurens, C; Louche, K; Miranda, J; Moro, C; Portillo, MP | 1 |
| El-Demerdash, E; Elsherbiny, DA; Gerges, SH; Wahdan, SA | 1 |
| Dej-Adisai, S; Heemman, A; Hong, BN; Jeong, SY; Kang, TH; Kim, NW; Nam, YH; Nuankaew, W; Shim, JH; Wattanapiromsakul, C; Yasmin, T | 1 |
| Becer, E; Hoca, M; Vatansever, HS | 1 |
| Bava, I; Bosco, F; Cardamone, A; Carresi, C; Coppoletta, AR; Gliozzi, M; Guarnieri, L; Macrì, R; Maiuolo, J; Mollace, R; Mollace, V; Musolino, V; Nucera, S; Palma, E; Ragusa, M; Ruga, S; Scarano, F; Scicchitano, M; Zito, MC | 1 |
| Buzzaccarini, G; Forte, G; Iervolino, M; Laganà, AS; Lepore, E; Unfer, V | 1 |
| Nie, Q; Song, G; Wang, C; Wang, X; Zhang, F; Zhang, X; Zhang, Z; Zhao, J | 1 |
| Chen, H; Zheng, T | 1 |
| Jayedi, A; Shab-Bidar, S; Zeraattalab-Motlagh, S | 1 |
| Rabbani, N; Thornalley, PJ; Weickert, MO; Xue, M | 1 |
| Jin, X; Ong, M; Peng, J; Qu, X | 1 |
| Chang, J; Cheng, J; Qin, L; Rui, Y; Shan, C; Wan, Z; Wang, G | 1 |
| Abbasi Oshaghi, E; Adeli, K; Goodarzi, MT; Higgins, V | 1 |
| Andrade, JMO; Caldeira, AP; de Almeida Pinheiro, T; De Farias Lelis, D; de Paula, AMB; Feltenberger, JD; Guimaraes, ALS; Neves Ferreira, EC; Sousa Santos, SH | 1 |
| Abdel-Aleem, GA; Khaleel, EF; Mostafa, DG | 1 |
| Alexandre, EC; André, DM; Anhê, GF; Antunes, E; Calixto, MC; Naime, ACA; Sollon, C; Tavares, EBG | 1 |
| Bircan, FS; Pasaoglu, OT; Turkozkan, N; Yilmaz Demirtas, C | 1 |
| Alexandre, EC; André, DM; Antunes, E; Calmasini, FB; de Oliveira, MG; Silva, FH; Tavares, EBG; Zapparoli, A | 1 |
| Bombrich, M; Fritsche, A; Fritsche, L; Häring, HU; Heni, M; Kantartzis, K; Kunz, I; Lehn-Stefan, A; Machann, J; Peter, A; Schick, F; Schoop, R; Staiger, H; Stefan, N | 1 |
| Jin, TR | 1 |
| Akash, MSH; Munawar, SM; Rehman, K; Saeed, K | 1 |
| Chen, S; Feng, X; Ke, L; Li, W; Li, Z; Zhang, Z; Zhao, Z; Zhou, Y; Zhu, W | 1 |
| Bruls, YMH; de Ligt, M; Habets, MF; Hansen, J; Havekes, B; Moonen-Kornips, E; Nascimento, EBM; Schaart, G; Schrauwen, P; Schrauwen-Hinderling, VB; van Marken Lichtenbelt, W | 1 |
| Bibby, BM; Grønbaek, H; Nellemann, B; Nielsen, S; Pedersen, SB; Poulsen, MK; Stødkilde-Jørgensen, H | 1 |
| Bai, Y; Chen, C; Cui, J; Lin, C; Wu, L; Zhang, H | 1 |
| Bai, Y; Cui, J; Lin, C; Song, W; Su, M; Sun, M; Wu, L; Zhang, H | 1 |
| Bai, YP; Cui, JQ; Lin, C; Song, WW; Su, M; Wu, L; Zhang, HY | 1 |
| Chang, SJ; Chang, YC; Chen, YA; Chen, YJ; Chen, YT; Liu, HW | 1 |
| Irwin-Houston, JM; Kornicka, K; Marycz, K; Weiss, C | 1 |
| Howe, PRC; Wong, RHX | 1 |
| Chen, M; Diao, J; Fan, G; Lin, L; Wei, J; Yan, R | 1 |
| Moco, S; Springer, M | 1 |
| Badi, RM; Khaleel, EF; Mostafa, DG; Satti, HH | 1 |
| Britton, SL; Csende, Z; Davies, KJ; Hart, N; Koch, LG; Koltai, E; Kouretas, D; Radak, Z; Sarga, L; Wessner, B | 1 |
| Cekanova, M; Greer, B; Kalupahana, NS; LeMieux, M; Moustaid-Moussa, N; Siriwardhana, N | 1 |
| Barzilai, N; Crandall, JP | 1 |
| Lam, YY; Peterson, CM; Ravussin, E | 1 |
| He, BL; Shen, LL; Wang, XM | 1 |
| Fujiwara, Y; Fukuhara, K; Hasebe, M; Ishii, A; Ito-Nagahata, T; Iwabuchi, M; Kurihara, C; Matsuoka, A; Sawada, R; Sonoda, M; Yamashita, K | 1 |
| Ayer, A; Baron, S; Beaudeux, JL; Bedarida, T; Cottart, CH; Henrion, D; Hommeril, B; Nivet-Antoine, V; Paul, JL; Procaccio, V; Renault, G; Saubamea, B; Vessieres, E; Vibert, F | 1 |
| Akar, F; Babacanoglu, C; Pektas, MB; Sadi, G; Yildirim, N | 1 |
| Carlson, OD; de Cabo, R; Doyle, ME; Egan, JM; Farhang, K; Fiori, JL; Gadkaree, SK; González-Mariscal, I; Kim, W; Krzysik-Walker, SM; Mattison, JA; Moaddel, R; Pearson, KJ; Sanghvi, M; Shin, YK | 1 |
| Chan, YH; Goh, KP; Koh, AF; Lau, DP; Lee, HY; Supaat, W | 1 |
| Hai, J; Li, K; Li, L; Li, Z; Peng, H; Weng, X; Zhang, Y | 1 |
| Dash, S; Lewis, GF; Morgantini, C; Szeto, L; Xiao, C | 1 |
| Beaudoin, MS; Herbst, EA; Holloway, GP; Neufer, PD; Perry, CG; Ritchie, IR; Smith, BK; Smith, JC; Wright, DC | 1 |
| Ho, CT; Lai, CS; Pan, MH; Tsai, ML | 1 |
| Dai, C; Hu, Y; Huang, R; Liu, J; Peng, X; Tu, Y; Wang, H; Wang, Y; Wu, J; Xia, Y; Zhai, Q; Zhang, F; Zhang, Y; Zhou, B | 1 |
| Dash, S; Lewis, GF; Morgantini, C; Xiao, C | 1 |
| Chachay, VS; Coombes, JS; Cowin, GJ; Ferguson, M; Franklin, M; Hickman, IJ; Kirkpatrick, CM; Klein, K; Lee, P; Macdonald, GA; Martin, JH; O'Moore-Sullivan, TM; Prins, JB; Taylor, PJ; Thomas, GP; Whitehead, JP | 1 |
| Koh, KK; Lim, S; Quon, MJ | 1 |
| Campagnole-Santos, MJ; de Paula, AM; dos Santos, RA; Ferreira, AV; Garcia, ZM; Guimarães, AL; Oliveira Andrade, JM; Paraíso, AF; Santos, SH; Sinisterra, RD; Sousa, FB | 1 |
| Liu, K; Mi, MT; Wang, B; Zhou, R | 1 |
| Mariman, EC; Noben, JP; Renes, J; Rosenow, A; Roumans, N | 1 |
| González-Ortiz, M; Lizárraga-Valdez, R; Martínez-Abundis, E; Méndez-del Villar, M; Pérez-Rubio, KG | 1 |
| Carpene, C; Carpene, MA; Deleruyelle, S; Gomez-Zorita, S | 1 |
| Baur, JA; Becker, LB; Guan, Y; Reilly, PM; Sims, CA; Wang, H; Widlund, AL | 1 |
| Almendros, I; Carreras, A; Gozal, D; Peris, E; Qiao, Z; Wang, Y; Zhang, SX | 2 |
| Dong, X; Li, P; Li, X; Sun, X; Wang, Q; Zhao, L | 1 |
| Chen, S; Gao, Y; Mi, M; Qin, Y; Ran, L; Shu, F; Wan, J; Wang, X; Yuan, L; Zhang, Q; Zhao, X | 1 |
| Sin, TK; Siu, PM; Yung, BY | 1 |
| Guijun, Q; Haohao, Z; Juan, Z; Lulu, C; Wen, K | 1 |
| Arias, N; Boqué, N; Etxeberria, U; Macarulla, MT; Martínez, JA; Milagro, FI; Portillo, MP | 1 |
| Álvarez, C; Cuadrado, A; Fernández-Millán, E; González-Rodríguez, Á; Mas-Gutierrez, JA; Pardo, V; Rada, P; Ros, M; Santamaría, B; Serrano, M; Valverde, ÁM | 1 |
| Baur, JA; Breen, DM; Côté, CD; Daljeet, M; Duca, FA; Filippi, BM; Lam, TK; Rasmussen, BA; Zadeh-Tahmasebi, M | 1 |
| Du, Q; Jiang, C; Liu, B; Liu, Z; Zhang, J | 1 |
| Chang, WC; Cheng, AS; Cheng, YH; Chung, CY; Lee, CY | 1 |
| Bagul, PK; Banerjee, SK | 1 |
| Hu, YJ; Liu, WX; Pan, QR; Ren, YL; Wang, G; Xu, Y; Zheng, JS | 1 |
| Adibi, P; Faghihzadeh, F; Hekmatdoost, A | 1 |
| Dolinsky, VW; Duhamel, T; McGavock, J; Robert, M; T' Jong, GW; Wicklow, B; Wittmeier, K | 1 |
| Breen, DM; Faubert, B; Giacca, A; Kwan, D; Moore, J; Nahle, A; Oprescu, AI; Park, E; Pereira, S; Tsiani, E | 1 |
| Ding, J; Li, H; Li, M; Wan, J; Wang, X; Wang, Y; Yao, L | 1 |
| Christensen, LP; Dudele, A; Ebbesen, LH; Jessen, N; Lund, S; Nøhr, MK; Pedersen, SB; Poulsen, MM; Radko, Y; Richelsen, B | 1 |
| Bendik, I; Blaak, EE; de Groot, P; Goossens, GH; Jocken, JW; Most, J; Schrauwen, P; Timmers, S; van Boekschoten, M; Warnke, I | 1 |
| Feng, X; Hou, T; Li, A; Liu, B; Liu, K; Zhang, N; Zhao, W | 1 |
| Feng, Y; Gu, N; Guo, Q; Hu, H; Jin, S; Li, L; Oh, Y; Wu, Q; Zhou, Y | 1 |
| Enghild, JJ; Knudsen, AD; Kroager, TP; Nøhr, MK; Pedersen, SB; Richelsen, B; Sanggaard, KW; Stensballe, A; Ølholm, J | 1 |
| Chen, G; Huang, H; Liao, D; Pu, R; Xue, X; Zhu, Y | 1 |
| Frendo-Cumbo, S; MacPherson, RE; Wright, DC | 1 |
| Ding, S; He, Q; Ji, L; Qi, Z; Xia, J; Xue, X | 1 |
| Bagul, PK; Banerjee, SK; Chakravarty, S; Jhelum, P; Kaur, G; Kumar, A; Kumar, KP; Maitra, S; Reddy, BR | 1 |
| Chen, LL; Hu, X; Kong, W; Wang, SX; Wei, JG | 1 |
| Banaszewska, B; Duleba, AJ; Pawelczyk, L; Spaczynski, RZ; Wrotyńska-Barczyńska, J | 1 |
| Ahuja, S; Choudhary, S; Kumar, A; Mourya, A; Sah, SP | 1 |
| Dehghan, P; Haghighi-Zadeh, MH; Hormoznejad, R; Ravanbakhsh, M; Yousefimanesh, HA; Zakerkish, M; Zare Javid, A | 1 |
| Angielski, S; Audzeyenka, I; Jankowski, M; Piwkowska, A; Rogacka, D | 1 |
| de Ligt, M; Hansen, J; Hesselink, MK; Kunz, I; Moonen-Kornips, E; Phielix, E; Schaart, G; Schrauwen, P; Schrauwen-Hinderling, VB; Timmers, S; van de Weijer, T | 1 |
| Berk, K; Chabowski, A; Charytoniuk, T; Drygalski, K; Konstantynowicz-Nowicka, K | 1 |
| Chen, G; Chen, L; Dai, F; Fang, Z; Gui, L; Lu, Y; Wang, N; Wang, T; Zhang, Q | 1 |
| Chen, Q; Li, J; Qiu, F; Wang, S; Wang, T; Yu, H; Zhang, Y | 1 |
| Byrne, NJ; Denou, E; Dyck, JR; Fung, D; Jones, KE; Kim, TT; Levasseur, J; Robertson, IM; Samokhvalov, V; Schertzer, JD; Seubert, JM; Soltys, CL; Sung, MM; Tyreman, N | 1 |
| Jessen, N; Jørgensen, JOL; Kjær, TN; Ornstrup, MJ; Pedersen, SB; Poulsen, MM; Richelsen, B; Stødkilde-Jørgensen, H | 1 |
| Aguirre, L; Contreras, J; Etxeberria, U; Macarulla, MT; Martínez, JA; Milagro, FI; Milton-Laskibar, I; Portillo, MP | 1 |
| Kjær, TN; Korsholm, AS; Ornstrup, MJ; Pedersen, SB | 1 |
| Barker, G; Lappas, M; Lim, R; Liong, S; Tran, HT | 1 |
| Lam, KS; Liu, L; Wang, Y; Xu, A | 1 |
| Chen, LL; Shang, J; Xiao, FX | 1 |
| Bell, D; Chuang, CC; Hopkins, R; Kennedy, A; Lapoint, K; Martinez, K; McIntosh, M; Overman, A; West, T | 1 |
| Baur, JA | 1 |
| Chung, JH; Foretz, M; Kang, H; Kim, MK; McBurney, MW; Park, SJ; Um, JH; Viollet, B; Yang, S | 1 |
| Avogaro, A; Bortoluzzi, A; Ceolotto, G; Cobelli, C; Dalla Man, C; de Kreutzenberg, SV; Fadini, GP; Papparella, I; Semplicini, A | 1 |
| Baolin, L; Fang, H; Heng, W; Kang, L; Yuan, A | 1 |
| Fullerton, MD; Steinberg, GR | 1 |
| Almeida, NA; Cordeiro, A; de Moura, EG; Franco, JG; Koury, JC; Lima, Nda S; Lisboa, PC; Passos, MC; Pazos-Moura, CC; Souza, LL; Trotta, PA | 1 |
| Bumrungpert, A; Chuang, CC; Jia, W; Kennedy, A; Martinez, K; McIntosh, MK; Overman, A; Xie, G | 1 |
| Feng, P; Li, J; Wang, N; Yang, J; Zhang, J | 1 |
| Cogger, VC; Desbiens, M; Garand, C; Labbé, A; Le Couteur, DG; Lebel, M; Paquet, ER | 1 |
| Carey, AL; Durand, C; El-Osta, A; Febbraio, MA; Fröjdö, S; Kingwell, BA; Molin, L; Pirola, L; Solari, F; Vidal, H | 1 |
| Szkudelska, K; Szkudelski, T | 1 |
| Brasnyó, P; Cseh, J; Halmai, R; Laczy, B; Markó, L; Mérei, A; Mészáros, LG; Mikolás, E; Mohás, M; Molnár, GA; Sümegi, B; Szijártó, IA; Wittmann, I | 1 |
| Chen, LL; Hu, D; Hu, X; Kong, W; Wang, SX; Zhang, HH; Zhang, P; Zheng, J | 1 |
| Assaad-Khalil, S; Bashmakov, YK; Petyaev, IM | 1 |
| Andrianjafiniony, T; Bergouignan, A; Blanc, S; Chery, I; Coxam, V; Desplanches, D; Falempin, M; Gauquelin-Koch, G; Momken, I; Picquet, F; Pujos-Guillot, E; Rudwill, F; Sebedio, JL; Simon, C; Stein, TP; Stevens, L; Zahariev, A; Zahn, S | 1 |
| Andersen, G; Burkon, A; Erbersdobler, HF; Fuhst, R; Leckband, G; Somoza, V; Sulzmaier, FJ; Walker, JM | 1 |
| Bianchi, C; Burgess, TA; Chu, LM; Robich, MP; Sellke, FW | 1 |
| Davidge, ST; Dolinsky, VW; Dyck, JR; Morton, JS; Rueda-Clausen, CF | 1 |
| Arrieta-Cruz, I; Barzilai, N; Gutierrez-Juarez, R; Huang, L; Knight, CM; Lam, TK; Rossetti, L; Schwartz, G | 1 |
| Guan, J; Han, CH; Hong, HJ; Kang, W; Kim, DG; Koh, G; Lee, DH; Lee, YJ; Park, D; Yang, EJ | 1 |
| Kim, YB; Lee, SH; Mantzoros, C | 1 |
| Das, DK; Fujitaka, K; Iwasaka, T; Iwasaki, M; Jo, F; Jo, H; Nishikawa, M; Nomura, E; Otani, H | 1 |
| Chen, LL; Hu, D; Hu, X; Kong, W; Zhang, HH; Zheng, J | 1 |
| Chen, S; Feng, X; Li, J; Li, W; Sun, Y; Zhang, Q; Zhang, Z; Zhu, W | 1 |
| Cho, GJ; Choi, WS; Jeon, BT; Jeong, EA; Kang, SS; Kim, HJ; Lee, DH; Lee, Y; Roh, GS; Shin, HJ | 1 |
| Calamaras, TD; Cohen, RA; Colucci, WS; Higuchi, A; Hou, X; Luptak, I; Miller, EJ; Ouchi, N; Qin, F; Siwik, DA; Tu, VH; Verbeuren, TJ; Walsh, K; Wang, L; Weisbrod, RM | 1 |
| Aujard, F; Blanc, S; Epelbaum, J; Marchal, J; Pifferi, F | 1 |
| Jung, TW; Ka, KH; Lee, KT; Lee, MW | 1 |
| Chen, SJ; Fu, XD; Liu, SP; Mu, PW; Tan, Z; Wang, TH; Zhou, LJ | 1 |
| Bagul, PK; Banerjee, SK; Bastia, T; Chakravarty, S; Madhusudana, K; Matapally, S; Middela, H; Padiya, R; Reddy, BR | 1 |
| Hoeks, J; Schrauwen, P | 1 |
| Accili, D; Farmer, SR; Gu, W; Kon, N; Lee, S; Qiang, L; Rosenbaum, M; Wang, L; Zhang, Y; Zhao, W; Zhao, Y | 1 |
| Koistinen, HA; Semenova, MM; Skrobuk, P; von Kraemer, S; Zitting, A | 1 |
| Chang, TL; Cheng, AS; Cheng, YH; Chiou, CH | 1 |
| Bianchi, C; Chu, LM; Elmadhun, NY; Lassaletta, AD; Sellke, FW | 1 |
| Amaral, TA; Franco, JG; Lima, NS; Lisboa, PC; Moura, EG; Oliveira, E; Passos, MC; Peixoto-Silva, N; Resende, AC | 1 |
| Christensen, LP; Clasen, BF; Jessen, N; Jørgensen, JO; Møller, N; Pedersen, SB; Poulsen, MM; Radko, Y; Stødkilde-Jørgensen, H; Vestergaard, PF | 1 |
| Ahn, YB; Kim, HW; Kim, JW; Ko, SH; Lee, EM; Lee, YE; Li, G; Liu, Z; Park, CW; Song, KH; Yoon, KH | 1 |
| Blagosklonny, MV; Demidenko, ZN; Leontieva, OV; Paszkiewicz, G | 1 |
| McCarty, MF | 1 |
| Cruzado, M; Miatello, R; Renna, N; Risler, N; Vázquez, M; Zumino, AP | 1 |
| Kaeberlein, M; Rabinovitch, PS | 1 |
| Argmann, C; Auwerx, J; Daussin, F; Elliott, P; Geny, B; Gerhart-Hines, Z; Laakso, M; Lagouge, M; Lambert, P; Lerin, C; Messadeq, N; Meziane, H; Milne, J; Puigserver, P | 1 |
| Ferré, P; Labie, D | 1 |
| Chen, X; Ge, X; Shi, X; Sun, C; Yan, T; Zhai, Q; Zhang, F | 1 |
34 review(s) available for resveratrol and Insulin Resistance
| Article | Year |
|---|---|
The effects of resveratrol on glycemic control and cardiometabolic parameters in patients with T2DM: A systematic review and meta-analysis.
Topics: Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Glycemic Control; Humans; Insulin Resistance; Resveratrol | 2022 |
Emerging Glycation-Based Therapeutics-Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors.
Topics: Animals; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Induction; Glutathione; Glycosylation; Hesperidin; Humans; Insulin Resistance; Lactoylglutathione Lyase; Mice; Molecular Structure; Neoplasms, Experimental; Obesity; Pyruvaldehyde; Resveratrol | 2022 |
The therapeutic effects and mechanisms of action of resveratrol on polycystic ovary syndrome: A comprehensive systematic review of clinical, animal and in vitro studies.
Topics: Animals; Female; Hormones; Humans; Insulin Resistance; Polycystic Ovary Syndrome; Resveratrol | 2022 |
Implications of Resveratrol in Obesity and Insulin Resistance: A State-of-the-Art Review.
Topics: Animals; Diabetes Mellitus, Type 2; Humans; Insulin; Insulin Resistance; Obesity; PPAR gamma; Resveratrol | 2022 |
Influence of Age and Dose on the Effect of Resveratrol for Glycemic Control in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis.
Topics: Age Distribution; Blood Glucose; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Glycemic Control; Humans; Insulin; Insulin Resistance; Insulins; Resveratrol | 2022 |
Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Topics: Alanine Transaminase; Anthocyanins; Aspartate Aminotransferases; Catechin; Cholesterol, HDL; Cholesterol, LDL; Curcumin; Dietary Supplements; Genistein; Hesperidin; Humans; Insulin Resistance; Non-alcoholic Fatty Liver Disease; Plant Extracts; Polyphenols; Resveratrol; Silymarin; Triglycerides | 2022 |
Efficacy of resveratrol supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials.
Topics: Dietary Supplements; Humans; Insulin Resistance; Non-alcoholic Fatty Liver Disease; Resveratrol; Triglycerides | 2021 |
Resveratrol supplementation and type 2 diabetes: a systematic review and meta-analysis.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Dietary Supplements; Glycated Hemoglobin; Humans; Insulin Resistance; Resveratrol | 2022 |
Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions.
Topics: Curcumin; Humans; Insulin Resistance; Liver; Liver Transplantation; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Obesity; Plant Preparations; Resveratrol; Risk Factors | 2021 |
The role of resveratrol in diabetes and obesity associated with insulin resistance.
Topics: Animals; Diabetes Mellitus; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Obesity; Resveratrol; Stilbenes | 2023 |
Potential of Nutraceutical Supplementation in the Modulation of White and Brown Fat Tissues in Obesity-Associated Disorders: Role of Inflammatory Signalling.
Topics: Adipogenesis; Adipose Tissue; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Curcumin; Diet; Dietary Supplements; Endoplasmic Reticulum; Fatty Acids, Unsaturated; Humans; Inflammation; Insulin Resistance; Intestines; Lipids; Macrophages; Obesity; Polyphenols; Resveratrol; Signal Transduction; Thermogenesis | 2021 |
Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review.
Topics: Ascorbic Acid; Dietary Supplements; Dyslipidemias; Fatty Acids, Omega-3; Female; Flavanones; Flavonoids; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Inositol; Insulin Resistance; Luteinizing Hormone; Ovulation; Polycystic Ovary Syndrome; Resveratrol; Vitamin D; Vitamin E; Vitamins | 2021 |
The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: an umbrella review of meta-analyses of randomized controlled trials.
Topics: Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Dietary Supplements; Humans; Insulin Resistance; Lipids; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Randomized Controlled Trials as Topic; Resveratrol | 2021 |
Chinese Herbal Medicine for the Optimal Management of Polycystic Ovary Syndrome.
Topics: Androgens; Berberine; Drugs, Chinese Herbal; Female; Ginsenosides; Glucosides; Humans; Insulin Resistance; Monoterpenes; Phenanthrenes; Phytotherapy; Polycystic Ovary Syndrome; Resveratrol; Stilbenes; Theca Cells | 2017 |
Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Mice; Resveratrol; Signal Transduction; Stilbenes | 2017 |
Curcumin and dietary polyphenol research: beyond drug discovery.
Topics: Animals; Anthocyanins; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cell Line; Curcumin; Drug Discovery; Fibroblast Growth Factors; Humans; Insulin; Insulin Resistance; Nuclear Proteins; Polyphenols; Resveratrol; Signal Transduction; Stilbenes; Transcription Factors | 2018 |
Resveratrol Counteracts Insulin Resistance-Potential Role of the Circulation.
Topics: Animals; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Muscle, Skeletal; Regional Blood Flow; Resveratrol; Vasodilation; Vasodilator Agents | 2018 |
Resveratrol and Its Human Metabolites-Effects on Metabolic Health and Obesity.
Topics: Adiposity; Animals; Energy Metabolism; Gastrointestinal Microbiome; Humans; Insulin Resistance; Models, Animal; Obesity; Phytoalexins; Polyphenols; Resveratrol; Sesquiterpenes | 2019 |
Modulation of adipose tissue inflammation by bioactive food compounds.
Topics: Adipose Tissue; Curcumin; Endocrine Glands; Fatty Acids; Food; Humans; Inflammation; Insulin Resistance; Polyphenols; Quercetin; Resveratrol; Stilbenes | 2013 |
Resveratrol vs. calorie restriction: data from rodents to humans.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Caloric Restriction; Dietary Supplements; Energy Metabolism; Humans; Insulin Resistance; Longevity; Oxidative Stress; Resveratrol; Risk Reduction Behavior; Rodentia; Sirtuin 1; Stilbenes | 2013 |
[Advance of resveratrol in treating diabetes mellitus].
Topics: Animals; Diabetes Mellitus, Experimental; Insulin Resistance; Resveratrol; Stilbenes | 2013 |
Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.
Topics: Adipokines; Animals; Carotenoids; Curcumin; Fatty Acids, Omega-3; Fatty Liver; Flavonols; Humans; Insulin Resistance; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Polyphenols; Resveratrol; Stilbenes | 2014 |
New and emerging regulators of intestinal lipoprotein secretion.
Topics: Animals; Apolipoprotein B-100; Apolipoprotein B-48; Atherosclerosis; Bile Acids and Salts; Cholesterol; Chylomicrons; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Dietary Fats; Dipeptidyl-Peptidase IV Inhibitors; Drug Evaluation, Preclinical; Dyslipidemias; Exenatide; Fatty Acids, Nonesterified; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucagon-Like Peptide-1 Receptor; Humans; Incretins; Insulin; Insulin Resistance; Intestine, Small; Lipoproteins; Microbiota; Peptides; Receptors, Glucagon; Resveratrol; Secretory Rate; Stilbenes; Triglycerides; Venoms | 2014 |
Modulation of adiponectin as a potential therapeutic strategy.
Topics: Adiponectin; Antihypertensive Agents; Atherosclerosis; Bariatric Surgery; Cardiovascular Diseases; Clinical Trials as Topic; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Reducing; Exercise; Humans; Hypoglycemic Agents; Insulin Resistance; Life Style; Metabolic Syndrome; Metabolism, Inborn Errors; Obesity; Peroxisome Proliferator-Activated Receptors; Receptors, Adiponectin; Resveratrol; Stilbenes | 2014 |
Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials.
Topics: Diabetes Mellitus, Type 2; Dietary Supplements; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes | 2014 |
Novel strategies for preventing diabetes and obesity complications with natural polyphenols.
Topics: Adipocytes; Animals; Diabetes Mellitus; Glucose; Humans; Hypoglycemic Agents; Insulin Resistance; Obesity; Polyphenols; Resveratrol; Stilbenes | 2015 |
Modulation of SIRT1-Foxo1 signaling axis by resveratrol: implications in skeletal muscle aging and insulin resistance.
Topics: Animals; Cellular Senescence; Forkhead Transcription Factors; Humans; Insulin Resistance; Muscle, Skeletal; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes | 2015 |
Application of resveratrol in diabetes: rationale, strategies and challenges.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antioxidants; Carbohydrate Metabolism; Cardiotonic Agents; Diabetes Mellitus; Enzyme Activation; Glucose Transporter Type 4; Humans; Hypoglycemic Agents; Insulin Resistance; Mice; Oxidative Stress; Rats; Resveratrol; Sirtuin 1; Stilbenes | 2015 |
The effects of resveratrol intervention on risk markers of cardiovascular health in overweight and obese subjects: a pooled analysis of randomized controlled trials.
Topics: Biomarkers; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Humans; Insulin Resistance; Meta-Analysis as Topic; Obesity; Overweight; Randomized Controlled Trials as Topic; Reproducibility of Results; Resveratrol; Risk Factors; Stilbenes | 2016 |
Alternative treatment methods attenuate the development of NAFLD: A review of resveratrol molecular mechanisms and clinical trials.
Topics: Complementary Therapies; Hepatocytes; Humans; Insulin Resistance; Lipid Metabolism; Liver; Non-alcoholic Fatty Liver Disease; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes | 2017 |
Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD).
Topics: Animals; Biological Products; Catechin; Curcumin; Fructose; Humans; Inflammation; Insulin Resistance; Lipogenesis; Mitochondria; Non-alcoholic Fatty Liver Disease; Resveratrol; Stilbenes | 2017 |
Moderate wine consumption in the prevention of metabolic syndrome and its related medical complications.
Topics: Alcohol Drinking; Animals; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Metabolic Syndrome; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes; Wine | 2008 |
Biochemical effects of SIRT1 activators.
Topics: Animals; Cardiotonic Agents; Energy Metabolism; Enzyme Activation; Heterocyclic Compounds, 4 or More Rings; Humans; Insulin Resistance; Learning; Longevity; Memory; Mice; Models, Biological; NAD; Neoplasms; Niacinamide; O-Acetyl-ADP-Ribose; Resveratrol; Silent Information Regulator Proteins, Saccharomyces cerevisiae; Sirtuin 1; Stilbenes | 2010 |
Anti-diabetic effects of resveratrol.
Topics: Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin Resistance; Resveratrol; Stilbenes | 2011 |
24 trial(s) available for resveratrol and Insulin Resistance
| Article | Year |
|---|---|
Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial.
Topics: Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Glucose; Hemostasis; Humans; Inflammation; Insulin Resistance; MicroRNAs; Oxidative Stress; Resveratrol | 2022 |
Effects of resveratrol therapy on glucose metabolism, insulin resistance, inflammation, and renal function in the elderly patients with type 2 diabetes mellitus: A randomized controlled clinical trial protocol.
Topics: Aged; Blood Glucose; Cytokines; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Inflammation; Insulin; Insulin Resistance; Kidney; Lipids; Randomized Controlled Trials as Topic; Resveratrol; Single-Blind Method | 2022 |
No effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: a randomized trial.
Topics: Adult; Aged; Body Composition; Dietary Supplements; Energy Metabolism; Female; Glycated Hemoglobin; Humans; Insulin Resistance; Male; Middle Aged; Overweight; Physical Functional Performance; Quality of Life; Resveratrol | 2020 |
Modulation of Energy Sensing by Leucine Synergy with Natural Sirtuin Activators: Effects on Health Span.
Topics: AMP-Activated Protein Kinases; Animals; Humans; Insulin Resistance; Leucine; Longevity; Mice, Obese; Prediabetic State; Resveratrol; Sirtuin 1; Stilbenes | 2020 |
Long-term effects of resveratrol on cognition, cerebrovascular function and cardio-metabolic markers in postmenopausal women: A 24-month randomised, double-blind, placebo-controlled, crossover study.
Topics: Aged; Aged, 80 and over; Cardiovascular Physiological Phenomena; Cerebrovascular Circulation; Cognition; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Female; Healthy Aging; Humans; Insulin; Insulin Resistance; Memory; Middle Aged; Postmenopause; Resveratrol | 2021 |
Reversal of Insulin Resistance in Overweight and Obese Subjects by
Topics: Adult; Blood Pressure; Body Mass Index; Carrier Proteins; Correlation of Data; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Glucose Metabolism Disorders; Glycosylation; Hesperidin; Humans; Inflammation; Inflammation Mediators; Insulin Resistance; Leukocytes, Mononuclear; Male; Obesity; Overweight; Pyruvaldehyde; Resveratrol; Tumor Necrosis Factor-alpha | 2021 |
Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial.
Topics: Adult; Aged; Antioxidants; Dietary Supplements; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Insulin Resistance; Intra-Abdominal Fat; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Overweight; Proton Magnetic Resonance Spectroscopy; Resveratrol | 2018 |
Resveratrol improves ex vivo mitochondrial function but does not affect insulin sensitivity or brown adipose tissue in first degree relatives of patients with type 2 diabetes.
Topics: Adipose Tissue, Brown; Aged; Diabetes Mellitus, Type 2; Fatty Acids; Glucose; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Mitochondria, Muscle; Pedigree; Resveratrol | 2018 |
No effect of resveratrol on VLDL-TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease.
Topics: Adult; Body Composition; Glucose Clamp Technique; Humans; Insulin Resistance; Kinetics; Lipoproteins, VLDL; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Resveratrol; Triglycerides | 2018 |
Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure.
Topics: AMP-Activated Protein Kinases; Basal Metabolism; Diabetes Mellitus, Type 2; Double-Blind Method; Energy Metabolism; Exercise; Glucose Transporter Type 4; Humans; Insulin Resistance; Male; Middle Aged; Muscle, Skeletal; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Physical Exertion; Plant Extracts; Rest; Resveratrol; Sirtuin 1; Stilbenes; Transcription Factors; Vitis | 2014 |
High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men.
Topics: Adult; Analysis of Variance; Apolipoprotein B-100; Apolipoprotein B-48; Biomarkers; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Insulin Resistance; Intestinal Mucosa; Intestines; Lipoproteins; Liver; Male; Middle Aged; Obesity; Ontario; Overweight; Resveratrol; Stilbenes; Time Factors; Treatment Outcome; Triglycerides | 2013 |
Resveratrol does not benefit patients with nonalcoholic fatty liver disease.
Topics: Abdominal Fat; Adult; Aged; Australia; Gastrointestinal Agents; Humans; Insulin Resistance; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Placebos; Resveratrol; Stilbenes; Treatment Outcome | 2014 |
Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion.
Topics: Adiposity; Adult; Area Under Curve; Biomarkers; Blood Glucose; Body Mass Index; Cholesterol, HDL; Double-Blind Method; Female; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Male; Metabolic Syndrome; Mexico; Middle Aged; Predictive Value of Tests; Resveratrol; Stilbenes; Time Factors; Treatment Outcome; Triglycerides; Weight Loss | 2014 |
Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Blood Glucose; Cholesterol; Cytokines; Double-Blind Method; Female; Homeostasis; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Resveratrol; Stilbenes; Ultrasonography; Young Adult | 2015 |
The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
Topics: Adult; Alanine Transaminase; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Blood Pressure; Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Fatty Liver; Female; Humans; Insulin Resistance; Lipid Metabolism; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Phytotherapy; Plant Extracts; Resveratrol; Risk Factors; Stilbenes; Triglycerides | 2015 |
Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are overweight or obese adolescents - rationale and protocol.
Topics: Administration, Oral; Adolescent; Dietary Supplements; Double-Blind Method; Female; Humans; Insulin Resistance; Male; Non-alcoholic Fatty Liver Disease; Overweight; Pediatric Obesity; Resveratrol; Stilbenes | 2015 |
Combined epigallocatechin-3-gallate and resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: a randomized controlled trial.
Topics: Adult; Blood Glucose; Catechin; Dietary Supplements; Double-Blind Method; Energy Metabolism; Fasting; Female; Humans; Insulin; Insulin Resistance; Intra-Abdominal Fat; Lipid Metabolism; Male; Mitochondria; Muscles; Obesity; Plant Extracts; Postprandial Period; Resveratrol; Stilbenes | 2016 |
Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial.
Topics: Adult; Antioxidants; Dehydroepiandrosterone Sulfate; Double-Blind Method; Female; Humans; Insulin; Insulin Resistance; Outcome Assessment, Health Care; Polycystic Ovary Syndrome; Resveratrol; Stilbenes; Testosterone | 2016 |
The Impact of Resveratrol Supplementation on Blood Glucose, Insulin, Insulin Resistance, Triglyceride, and Periodontal Markers in Type 2 Diabetic Patients with Chronic Periodontitis.
Topics: Blood Glucose; Chronic Periodontitis; Double-Blind Method; Female; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Resveratrol; Stilbenes; Triglycerides | 2017 |
Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial.
Topics: Adult; Aged; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Metformin; Middle Aged; Resveratrol; Stilbenes | 2016 |
No Beneficial Effects of Resveratrol on the Metabolic Syndrome: A Randomized Placebo-Controlled Clinical Trial.
Topics: Absorptiometry, Photon; Adipose Tissue; Antioxidants; Blood Glucose; Blood Pressure; Blotting, Western; Body Composition; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Fructosamine; Humans; Insulin; Insulin Resistance; Interleukin-6; Intra-Abdominal Fat; Leptin; Liver; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Metabolic Syndrome; Middle Aged; Muscle, Skeletal; Quadriceps Muscle; Real-Time Polymerase Chain Reaction; Receptors, Urokinase Plasminogen Activator; Resveratrol; Stilbenes; Triglycerides | 2017 |
Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.
Topics: Adult; Blood Platelets; Diabetes Mellitus, Type 2; Double-Blind Method; Humans; Insulin Resistance; Male; Middle Aged; Oxidative Stress; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes; Tyrosine | 2011 |
Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment.
Topics: Aged; Diabetes Mellitus; Drug Compounding; Endothelium, Vascular; Female; Humans; Hyperlipidemias; Hypertension; Insulin Resistance; Life Style; Male; Metabolic Syndrome; Middle Aged; Resveratrol; Stilbenes; Vasodilation; Vasodilator Agents | 2011 |
High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.
Topics: Adolescent; Adult; Aged; Antioxidants; Body Composition; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Energy Metabolism; Gene Expression Regulation; Humans; Insulin Resistance; Male; Middle Aged; Obesity; Pilot Projects; Resveratrol; Stilbenes; Young Adult | 2013 |
127 other study(ies) available for resveratrol and Insulin Resistance
| Article | Year |
|---|---|
Comparative analysis of long non‑coding RNA expression profiles induced by resveratrol and metformin treatment for hepatic insulin resistance.
Topics: Animals; Diet, High-Fat; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation; Gene Ontology; Insulin Resistance; Liver; Male; Metformin; Mice, Inbred C57BL; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; RNA, Long Noncoding; RNA, Messenger; Signal Transduction | 2021 |
Transcriptome-Based Analysis Reveals Therapeutic Effects of Resveratrol on Endometriosis in aRat Model.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Endometriosis; Female; Insulin Resistance; Lipid Metabolism; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Transcriptome | 2021 |
Label-free study of intracellular glycogen level in metformin and resveratrol-treated insulin-resistant HepG2 by live-cell FTIR spectroscopy.
Topics: Biosensing Techniques; Glycogen; Humans; Insulin; Insulin Resistance; Metformin; Resveratrol; Spectroscopy, Fourier Transform Infrared | 2022 |
Grafting resveratrol onto mesoporous silica nanoparticles towards efficient sustainable immunoregulation and insulin resistance alleviation for diabetic periodontitis therapy.
Topics: Diabetes Mellitus; Glucose; Humans; Insulin Resistance; Nanoparticles; Periodontitis; Resveratrol; Silicon Dioxide | 2022 |
Anti-diabetic effect of cotreatment with resveratrol and pioglitazone in diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Insulin Resistance; Lipids; Oxidative Stress; Pioglitazone; Rats; Rats, Sprague-Dawley; Resveratrol | 2023 |
Brain targeted peptide-functionalized chitosan nanoparticles for resveratrol delivery: Impact on insulin resistance and gut microbiota in obesity-related Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Blood-Brain Barrier; Chitosan; Gastrointestinal Microbiome; Insulin Resistance; Mice; Nanoparticles; Peptides; Resveratrol | 2023 |
Resveratrol-loaded selenium/chitosan nano-flowers alleviate glucolipid metabolism disorder-associated cognitive impairment in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Chitosan; Cognitive Dysfunction; Insulin Resistance; Lipopolysaccharides; Mice; Resveratrol; Selenium; tau Proteins | 2023 |
Resveratrol improves palmitic acid‑induced insulin resistance via the DDIT4/mTOR pathway in C2C12 cells.
Topics: Culture Media; Humans; Insulin Resistance; Palmitic Acid; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Messenger; TOR Serine-Threonine Kinases; Transcription Factors | 2023 |
Resveratrol and Metformin Recover Prefrontal Cortex AMPK Activation in Diet-Induced Obese Mice but Reduce BDNF and Synaptophysin Protein Content.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Autophagy; Blood Glucose; Brain-Derived Neurotrophic Factor; Diet, High-Fat; Enzyme Activation; Hypoglycemic Agents; Insulin Resistance; Male; Metformin; Mice; Mice, Inbred C57BL; Obesity; Prefrontal Cortex; Resveratrol; Synaptophysin; TOR Serine-Threonine Kinases | 2019 |
Hypoglycaemic effect of resveratrol in streptozotocin-induced diabetic rats is impaired when supplemented in association with leucine.
Topics: Adipocytes; Adipose Tissue; Adipose Tissue, White; Adiposity; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Dietary Supplements; Drug Interactions; Fruit; Hypoglycemic Agents; Insulin; Insulin Resistance; Leucine; Male; Phytotherapy; Rats; Resveratrol | 2020 |
Resveratrol ameliorates high-fat diet-induced insulin resistance and fatty acid oxidation via ATM-AMPK axis in skeletal muscle.
Topics: Animals; Ataxia Telangiectasia Mutated Proteins; Cells, Cultured; Diet, High-Fat; Down-Regulation; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Oxidative Stress; Random Allocation; Resveratrol; Triglycerides | 2019 |
Amelioration of insulin resistance using the additive effect of ferulic acid and resveratrol on vesicle trafficking for skeletal muscle glucose metabolism.
Topics: Animals; Biological Transport; Cells, Cultured; Coumaric Acids; Cytoplasmic Vesicles; Drug Synergism; Energy Metabolism; Glucose; Hep G2 Cells; Humans; Insulin; Insulin Resistance; Muscle Fibers, Skeletal; Muscle, Skeletal; Rats; Resveratrol | 2020 |
Resveratrol ameliorates metabolic disorders and insulin resistance in high-fat diet-fed mice.
Topics: Adipose Tissue; Animals; Antioxidants; Blood Glucose; Diet, High-Fat; Hep G2 Cells; Humans; Insulin Resistance; Lipid Metabolism; Liver; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Oxidative Stress; Resveratrol; Triglycerides | 2020 |
The Putative Caloric Restriction Mimetic Resveratrol has Moderate Impact on Insulin Sensitivity, Body Composition, and the Metabolome in Mice.
Topics: Animals; Bibenzyls; Body Composition; Caloric Restriction; Dietary Supplements; Gene Expression Regulation; Glucose Tolerance Test; Glycoside Hydrolase Inhibitors; Insulin; Insulin Resistance; Leptin; Liver; Male; Metabolome; Mice, Inbred C57BL; Phenols; Resveratrol; Stilbenes | 2020 |
Amelioration of High-Insulin-Induced Skeletal Muscle Cell Insulin Resistance by Resveratrol Is Linked to Activation of AMPK and Restoration of GLUT4 Translocation.
Topics: AMP-Activated Protein Kinases; Animals; Cell Line; Glucose Transporter Type 4; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Muscle, Skeletal; Rats; Resveratrol; TOR Serine-Threonine Kinases | 2020 |
Effect of resveratrol on intestinal tight junction proteins and the gut microbiome in high-fat diet-fed insulin resistant mice.
Topics: Animals; Bacteria; Diet, High-Fat; Disease Models, Animal; Feces; Firmicutes; Gastrointestinal Microbiome; Gastrointestinal Tract; Glucose Intolerance; Inflammation; Insulin; Insulin Resistance; Lipids; Male; Mice; Mice, Inbred C57BL; Resveratrol; RNA, Ribosomal, 16S; Tight Junction Proteins | 2020 |
NLRP3 inflammasome drives inflammation in high fructose fed diabetic rat liver: Effect of resveratrol and metformin.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fructose; Hypoglycemic Agents; Inflammasomes; Inflammation; Insulin Resistance; Liver; Male; Metformin; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley; Resveratrol | 2020 |
Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
Topics: Animals; Antioxidants; Bacteroides; Body Weight; Clostridiales; Diet, High-Fat; Fatty Liver; Firmicutes; Gastrointestinal Microbiome; Inflammation; Insulin Resistance; Intestinal Mucosa; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Resveratrol | 2020 |
Effects of Maternal Resveratrol on Maternal High-Fat Diet/Obesity with or without Postnatal High-Fat Diet.
Topics: Adiponectin; Animals; Antioxidants; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Diet, High-Fat; Female; Humans; Insulin Resistance; Male; Maternal Nutritional Physiological Phenomena; Maze Learning; Obesity; Placenta; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Resveratrol; Weaning | 2020 |
Resveratrol improves lipid metabolism in diabetic nephropathy rats.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Autophagy; Diabetic Nephropathies; Disease Models, Animal; Enzyme Activation; Humans; Insulin Resistance; Lipid Metabolism; Male; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Streptozocin; TOR Serine-Threonine Kinases | 2020 |
Long non-coding RNA expression profiling following treatment with resveratrol to improve insulin resistance.
Topics: Animals; Cell Line, Tumor; Diabetes Mellitus, Type 2; Gene Expression; Glucose-6-Phosphatase; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Resveratrol; RNA, Long Noncoding; Suppressor of Cytokine Signaling 3 Protein | 2020 |
Attenuation of Free Fatty Acid (FFA)-Induced Skeletal Muscle Cell Insulin Resistance by Resveratrol is Linked to Activation of AMPK and Inhibition of mTOR and p70 S6K.
Topics: Adenylate Kinase; Animals; Cell Line; Fatty Acids, Nonesterified; Glucose; Glucose Transporter Type 4; Humans; Insulin Receptor Substrate Proteins; Insulin Resistance; Muscle Cells; Muscle, Skeletal; Palmitates; Phosphorylation; Protein Processing, Post-Translational; Protein Transport; Rats; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases | 2020 |
Dodging physical activity and healthy diet: can resveratrol take the edge off the consequences of your lifestyle?
Topics: Adult; Diet, Healthy; Dietary Supplements; Exercise; Humans; Insulin Resistance; Life Style; Overweight; Resveratrol | 2020 |
Resveratrol Inhibits Neointimal Growth after Arterial Injury in High-Fat-Fed Rodents: The Roles of SIRT1 and AMPK.
Topics: AMP-Activated Protein Kinases; Animals; Carotid Artery Injuries; Carotid Artery, Common; Diet, High-Fat; Disease Models, Animal; Femoral Artery; Insulin Resistance; Mice, Knockout; Neointima; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Sirtuin 1; Vascular System Injuries | 2020 |
Supplementation with Red Wine Extract Increases Insulin Sensitivity and Peripheral Blood Mononuclear Sirt1 Expression in Nondiabetic Humans.
Topics: Adult; Aged; Alanine Transaminase; AMP-Activated Protein Kinases; Aspartate Aminotransferases; Biomarkers; Blood Glucose; Female; gamma-Glutamyltransferase; Humans; Insulin Resistance; Interleukin-6; Leukocytes, Mononuclear; Lipid Metabolism; Male; Middle Aged; Polyphenols; Resveratrol; Sirtuin 1; THP-1 Cells; Triglycerides; Wine; Young Adult | 2020 |
Effect of resveratrol on behavioral, biochemical, and immunological parameters of DBA/2J and tetrahybrid DBCB mice receiving diet with excess fat and fructose.
Topics: Animals; Antioxidants; Behavior, Animal; Diet, High-Fat; Dietary Carbohydrates; Dietary Fats; Elevated Plus Maze Test; Fructose; Ghrelin; Inflammation; Insulin Resistance; Interleukin-10; Interleukin-3; Leptin; Male; Mice; Mice, Inbred DBA; Obesity; Resveratrol; Triglycerides | 2021 |
Resveratrol-induced remodelling of myocellular lipid stores: A study in metabolically compromised humans.
Topics: Antioxidants; Athletes; Biopsy; Diabetes Mellitus, Type 2; Exercise; Humans; Insulin Resistance; Lipid Droplets; Lipid Metabolism; Middle Aged; Muscle Fibers, Skeletal; Muscle, Skeletal; Primary Cell Culture; Quadriceps Muscle; Randomized Controlled Trials as Topic; Resveratrol | 2021 |
Effects of Physiological Doses of Resveratrol and Quercetin on Glucose Metabolism in Primary Myotubes.
Topics: Adult; AMP-Activated Protein Kinases; Diabetes Mellitus; Drug Evaluation, Preclinical; Fatty Acids; Glucose; Healthy Volunteers; Humans; Insulin Resistance; Lactic Acid; Male; Mitochondria; Muscle Fibers, Skeletal; Oxidation-Reduction; Phosphorylation; Primary Cell Culture; Proto-Oncogene Proteins c-akt; Quercetin; Resveratrol; Signal Transduction | 2021 |
Anti-insulin resistance effect of constituents from Senna siamea on zebrafish model, its molecular docking, and structure-activity relationships.
Topics: alpha-Glucosidases; Animals; Anthraquinones; Diabetes Mellitus; Dipeptidyl Peptidase 4; Emodin; Hypoglycemic Agents; Insulin Resistance; Molecular Docking Simulation; Molecular Structure; Plant Extracts; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Resveratrol; Senna Plant; Stilbenes; Structure-Activity Relationship; Thailand; Wood; Zebrafish | 2021 |
Resveratrol affects the expression of uric acid transporter by improving inflammation.
Topics: Animals; Blood Glucose; Body Weight; CARD Signaling Adaptor Proteins; Caspase 1; Chemokine CCL2; Cytokines; Diet, High-Fat; Disease Models, Animal; Glucose Transport Proteins, Facilitative; Inflammation; Insulin Resistance; Kidney; Male; MAP Kinase Kinase Kinases; Membrane Transport Proteins; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Organic Anion Transporters; Resveratrol; TNF Receptor-Associated Factor 6; Toll-Like Receptor 4; Uric Acid | 2021 |
Resveratrol ameliorates the glucose uptake and lipid metabolism in gestational diabetes mellitus mice and insulin-resistant adipocytes via miR-23a-3p/NOV axis.
Topics: Adipocytes; Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes, Gestational; Diet, High-Fat; Disease Models, Animal; Female; Glucose; Insulin; Insulin Resistance; Lipid Metabolism; Mice; MicroRNAs; Nephroblastoma Overexpressed Protein; Pregnancy; Proto-Oncogene Proteins c-akt; Resveratrol; Wilms Tumor | 2021 |
Effects of vitamin D and resveratrol on metabolic associated markers in liver and adipose tissue from SAMP8 mice.
Topics: Adipose Tissue; Aging; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Blood Glucose; Body Weight; Drug Combinations; Drug Evaluation, Preclinical; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Glucose Tolerance Test; Insulin Resistance; Liver; Male; Mice, Mutant Strains; Organ Size; Oxidative Stress; Resveratrol; Stilbenes; Vitamin D | 2017 |
Effects of Resveratrol and ACE Inhibitor Enalapril on Glucose and Lipid Profiles in Mice.
Topics: Adipocytes; Adipogenesis; Adipose Tissue, White; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Body Weight; Diet, High-Fat; Enalapril; Humans; Insulin Resistance; Lipid Metabolism; Lipogenesis; Male; Mice; Resveratrol; Stilbenes | 2017 |
Resveratrol improves high-fat diet induced fatty liver and insulin resistance by concomitantly inhibiting proteolytic cleavage of sterol regulatory element-binding proteins, free fatty acid oxidation, and intestinal triglyceride absorption.
Topics: Animals; Antioxidants; Area Under Curve; Diet, High-Fat; Fatty Acids, Nonesterified; Fatty Liver; Feces; Gene Expression Regulation; Glucose; Glucose Tolerance Test; Insulin Resistance; Intestinal Absorption; Lipase; Liver; Male; Organ Size; Oxidation-Reduction; Oxidative Stress; Proteolysis; Rats, Wistar; Resveratrol; RNA, Messenger; Sterol Regulatory Element Binding Proteins; Stilbenes; Triglycerides | 2018 |
High-fat diet-induced obesity impairs insulin signaling in lungs of allergen-challenged mice: Improvement by resveratrol.
Topics: Allergens; Animals; Asthma; Diet, High-Fat; Insulin; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Phosphorylation; Pneumonia; Receptor, Insulin; Resveratrol; Signal Transduction | 2017 |
The effects of resveratrol on hepatic oxidative stress in metabolic syndrome model induced by high fructose diet.
Topics: Animals; Antioxidants; Fructose; Glutathione Peroxidase; Insulin Resistance; Liver; Male; Metabolic Syndrome; Oxidants; Oxidative Stress; Rats; Resveratrol; Stilbenes; Superoxide Dismutase | 2018 |
Obesity-induced mouse benign prostatic hyperplasia (BPH) is improved by treatment with resveratrol: implication of oxidative stress, insulin sensitivity and neuronal growth factor.
Topics: Animals; Body Weight; Insulin Resistance; Male; Mice, Inbred C57BL; NADPH Oxidase 2; Nerve Growth Factor; Obesity; Oxidative Stress; Prostate; Prostatic Hyperplasia; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Resveratrol | 2018 |
Resveratrol regulates hyperglycemia-induced modulations in experimental diabetic animal model.
Topics: Animals; Antioxidants; Blood Glucose; Calcium; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Hyperglycemia; Insulin; Insulin Resistance; Magnesium; Male; Metformin; Rats; Resveratrol; Stilbenes; Vitamin E | 2018 |
Resveratrol improves glucose uptake in insulin-resistant adipocytes via Sirt1.
Topics: 3T3-L1 Cells; Adipocytes; AMP-Activated Protein Kinases; Animals; Cells, Cultured; Forkhead Box Protein O1; Glucose; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Sirtuin 1 | 2018 |
[Effects of exercise and resveratrol on visceral fat resistin expression and plasma resistin concentration in elderly obese rats].
Topics: Adipose Tissue; Aging; Animals; Blood Glucose; Insulin; Insulin Resistance; Intra-Abdominal Fat; Obesity; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Resistin; Resveratrol | 2016 |
[Effects of exercise and resveratrol on retinol binding protein 4, blood glucose and insulin sensitivity in aged obese rats].
Topics: Adipose Tissue; Aged; Animals; Blood Glucose; Exercise; Humans; Insulin; Insulin Resistance; Obesity; Rats; Rats, Sprague-Dawley; Resveratrol; Retinol-Binding Proteins, Plasma | 2017 |
[Effects of different intensities exercise combined with resveratrol on RBP4 in aged obese rats].
Topics: Aging; Animals; Insulin Resistance; Male; Obesity; Physical Conditioning, Animal; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Retinol-Binding Proteins, Plasma; Stilbenes | 2017 |
Resveratrol protects muscle cells against palmitate-induced cellular senescence and insulin resistance through ameliorating autophagic flux.
Topics: Animals; Apoptosis; Autophagy; Cell Line; Cellular Senescence; Insulin; Insulin Resistance; Mice; Muscle Cells; Muscle Fibers, Skeletal; Muscle, Skeletal; Palmitates; Proto-Oncogene Proteins c-akt; Resveratrol | 2018 |
Combination of resveratrol and 5-azacytydine improves osteogenesis of metabolic syndrome mesenchymal stem cells.
Topics: Adipose Tissue; Animals; Autophagy; Azacitidine; Cell Differentiation; Cellular Senescence; Collagen Type I; Core Binding Factor Alpha 1 Subunit; Drug Combinations; Female; Gene Expression Regulation; Horse Diseases; Horses; Insulin Resistance; Male; Mesenchymal Stem Cells; Metabolic Syndrome; Mitochondrial Dynamics; Obesity; Osteoblasts; Osteogenesis; Osteopontin; Oxidative Stress; Reactive Oxygen Species; Resveratrol; RNA, Small Interfering; Signal Transduction; Ubiquitin-Protein Ligases | 2018 |
Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats.
Topics: Animals; Antioxidants; Apoptosis; Cardiotonic Agents; Cell Line; Cholesterol, LDL; Cytochromes c; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Diet, High-Fat; Gene Expression Regulation; Glucose; Insulin Resistance; Male; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardium; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Streptozocin; Triglycerides; Uncoupling Protein 2 | 2019 |
Resveratrol protects against hepatic insulin resistance in a rat's model of non-alcoholic fatty liver disease by down-regulation of GPAT-1 and DGAT2 expression and inhibition of PKC membranous translocation.
Topics: Animals; Body Weight; Cell Membrane; Diacylglycerol O-Acyltransferase; Disease Models, Animal; Down-Regulation; Eating; Enzyme Activation; Glycerol-3-Phosphate O-Acyltransferase; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Liver; Male; Non-alcoholic Fatty Liver Disease; Protein Kinase C; Protein Transport; Rats; Rats, Wistar; Resveratrol; Signal Transduction | 2019 |
Resveratrol enhances exercise training responses in rats selectively bred for high running performance.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Biomarkers; DNA-Binding Proteins; Insulin Resistance; Male; Mitochondria; Mitochondrial Proteins; Oxidative Stress; Physical Conditioning, Animal; Protein Carbonylation; Rats; Reactive Oxygen Species; Resveratrol; Running; Sirtuin 1; Stilbenes; Transcription Factors | 2013 |
Exploring the promise of resveratrol: where do we go from here?
Topics: Antioxidants; Body Composition; Humans; Insulin Resistance; Male; Obesity; Resveratrol; Stilbenes | 2013 |
Stilbene analogs of resveratrol improve insulin resistance through activation of AMPK.
Topics: 3T3-L1 Cells; Adipocytes; AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucose; Humans; Insulin; Insulin Resistance; Mice; Obesity; Resveratrol; Stilbenes | 2013 |
Dual effects of resveratrol on arterial damage induced by insulin resistance in aged mice.
Topics: Aging; Animals; Antioxidants; Aorta; Blood Glucose; Chemokine CCL5; Chemokine CXCL1; Dietary Proteins; Disease Models, Animal; Insulin Resistance; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Nutritional Status; Oxidative Stress; Phenols; Resistin; Resveratrol; Ribonucleotide Reductases; Serum Albumin; Stilbenes; Superoxides; Tumor Necrosis Factor-alpha; Vascular Capacitance; Vascular Diseases; Vasodilation | 2014 |
Resveratrol prevents high-fructose corn syrup-induced vascular insulin resistance and dysfunction in rats.
Topics: Animals; Body Weight; Cholesterol, VLDL; Endothelin-1; Fructose; Gene Expression; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Resveratrol; RNA, Messenger; Stilbenes; Sweetening Agents; Triglycerides | 2013 |
Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet.
Topics: Animals; Blood Glucose; Body Weight; Cell Dedifferentiation; Densitometry; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dietary Sucrose; Disease Models, Animal; Fluorescent Antibody Technique; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucose Tolerance Test; Glycated Hemoglobin; Homeobox Protein Nkx-2.2; Homeodomain Proteins; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Macaca mulatta; Nuclear Proteins; Protective Agents; Resveratrol; Sirtuin 1; Stilbenes; Transcription Factors | 2013 |
Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease.
Topics: Animals; Autophagy; Diet, High-Fat; Disease Models, Animal; DNA Primers; Fatty Liver; Inflammation; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Oxidative Stress; Polymerase Chain Reaction; Resveratrol; Stilbenes | 2014 |
Submaximal ADP-stimulated respiration is impaired in ZDF rats and recovered by resveratrol.
Topics: Adenine Nucleotide Translocator 2; Adenosine Diphosphate; Animals; Cell Respiration; Diabetes Mellitus, Type 2; Glutathione; Glutathione Disulfide; Hydrogen Peroxide; Insulin Resistance; Male; Mitochondria; Muscle, Skeletal; Rats; Rats, Zucker; Resveratrol; Stilbenes | 2013 |
CLOCK/BMAL1 regulates circadian change of mouse hepatic insulin sensitivity by SIRT1.
Topics: Animals; Antioxidants; ARNTL Transcription Factors; Circadian Rhythm; CLOCK Proteins; Darkness; Down-Regulation; Hepatocytes; Insulin Resistance; Liver; Mice; Mice, Knockout; Promoter Regions, Genetic; Resveratrol; Sirtuin 1; Stilbenes | 2014 |
Cross talk between angiotensin-(1-7)/Mas axis and sirtuins in adipose tissue and metabolism of high-fat feed mice.
Topics: Administration, Oral; Angiotensin I; Animals; Antimetabolites; Cells, Cultured; Diet, High-Fat; Drug Evaluation, Preclinical; Gene Expression; Glucose Intolerance; Hyperinsulinism; Insulin Resistance; Intra-Abdominal Fat; Lipolysis; Male; Mice; Obesity; Peptide Fragments; Primary Cell Culture; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Resistin; Resveratrol; Sirtuins; Stilbenes | 2014 |
Calorie restriction-induced changes in the secretome of human adipocytes, comparison with resveratrol-induced secretome effects.
Topics: Adipocytes; Adipokines; Adipose Tissue, White; Antioxidants; Arrhythmias, Cardiac; Caloric Restriction; Cells, Cultured; Electrophoresis, Gel, Two-Dimensional; Gene Expression Regulation; Genetic Diseases, X-Linked; Gigantism; Glucose; Heart Defects, Congenital; Humans; Insulin Resistance; Intellectual Disability; Molecular Sequence Annotation; Obesity; Proteome; Proteomics; Resveratrol; Sirtuin 1; Stilbenes; Tandem Mass Spectrometry | 2014 |
Resveratrol ameliorates mitochondrial dysfunction but increases the risk of hypoglycemia following hemorrhagic shock.
Topics: Animals; Blood Glucose; Corticosterone; Glucagon; Glucagon-Like Peptide 1; Hypoglycemia; Insulin; Insulin Resistance; Kidney; Male; Mitochondria; Mitochondria, Liver; Rats, Long-Evans; Reactive Oxygen Species; Resuscitation; Resveratrol; Shock, Hemorrhagic; Stilbenes | 2014 |
Effect of resveratrol on visceral white adipose tissue inflammation and insulin sensitivity in a mouse model of sleep apnea.
Topics: Animals; Anti-Obesity Agents; Diet, High-Fat; Disease Models, Animal; Eating; Inflammation; Insulin Resistance; Intra-Abdominal Fat; Male; Mice; Mice, Inbred C57BL; Obesity; Resveratrol; Sleep Apnea Syndromes; Stilbenes; Tumor Necrosis Factor-alpha; Weight Gain | 2015 |
Resveratrol attenuates intermittent hypoxia-induced insulin resistance in rats: involvement of Sirtuin 1 and the phosphatidylinositol-4,5-bisphosphate 3-kinase/AKT pathway.
Topics: Animals; Blood Glucose; Body Weight; Gene Expression Regulation; Glucose Transporter Type 2; Hypoxia; Insulin; Insulin Resistance; Liver; Male; Phosphatidylinositol 3-Kinases; Phosphorylation; Protective Agents; Proto-Oncogene Proteins c-akt; Rats; Receptor, Insulin; Resveratrol; RNA, Messenger; Signal Transduction; Sirtuin 1; Stilbenes | 2015 |
Resveratrol attenuates intermittent hypoxia-induced macrophage migration to visceral white adipose tissue and insulin resistance in male mice.
Topics: Animals; Anti-Obesity Agents; Drug Evaluation, Preclinical; Eating; Hypoxia; Insulin; Insulin Resistance; Intra-Abdominal Fat; Leptin; Macrophages; Male; Mice, Inbred C57BL; Random Allocation; Resveratrol; Stilbenes; Weight Gain | 2015 |
Resveratrol improves high-fat diet induced insulin resistance by rebalancing subsarcolemmal mitochondrial oxidation and antioxidantion.
Topics: Animals; Antioxidants; Diet, High-Fat; DNA, Mitochondrial; Insulin; Insulin Resistance; Male; Mitochondria; Muscle, Skeletal; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Sirtuin 3; Stilbenes | 2015 |
Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats.
Topics: Animals; Bacillus; Bacteroidetes; Diet, High-Fat; Dietary Supplements; DNA, Bacterial; Fatty Acids, Volatile; Feces; Firmicutes; Gas Chromatography-Mass Spectrometry; Gastrointestinal Microbiome; Gastrointestinal Tract; Insulin Resistance; Obesity; Quercetin; Rats; Rats, Wistar; Resveratrol; Stilbenes; Sucrose; Weight Gain | 2015 |
Resveratrol treatment restores peripheral insulin sensitivity in diabetic mice in a sirt1-independent manner.
Topics: Animals; Antioxidants; Crosses, Genetic; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Supplements; Enzyme Inhibitors; Female; Hypoglycemic Agents; Insulin Receptor Substrate Proteins; Insulin Resistance; Islets of Langerhans; Liver; Male; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Muscle, Skeletal; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Resveratrol; Sirtuin 1; Stilbenes | 2015 |
Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus; Disease Models, Animal; Gene Expression Regulation; HEK293 Cells; Homeostasis; Humans; Insulin; Insulin Resistance; Male; Nerve Net; Neurons; Niacinamide; Obesity; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Stilbenes; Streptozocin | 2015 |
Resveratrol inhibits inflammation and ameliorates insulin resistant endothelial dysfunction via regulation of AMP-activated protein kinase and sirtuin 1 activities.
Topics: AMP-Activated Protein Kinases; Animals; Blotting, Western; Cytokines; Diabetes Mellitus, Experimental; Endothelium, Vascular; Fructose; Gene Expression Regulation; Inflammation; Insulin Resistance; Male; Microscopy, Fluorescence; Nitric Oxide; Phosphorylation; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; Vasodilation | 2016 |
Resveratrol protects against methylglyoxal-induced hyperglycemia and pancreatic damage in vivo.
Topics: Animals; Anti-Inflammatory Agents; Blood Glucose; Disease Models, Animal; Glucose Tolerance Test; Hyperglycemia; Hypoglycemic Agents; Inflammation; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Male; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; Pancreas; Pancreatic Diseases; Phosphorylation; Pyruvaldehyde; Resveratrol; Stilbenes | 2015 |
Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats.
Topics: Animals; Diet, High-Fat; Dyslipidemias; Endoplasmic Reticulum Stress; Gene Expression; Inflammation; Insulin Resistance; Lipid Metabolism; Liver; Male; Non-alcoholic Fatty Liver Disease; Phytotherapy; Plant Extracts; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2015 |
Resveratrol prevents insulin resistance caused by short-term elevation of free fatty acids in vivo.
Topics: Animals; Biomarkers; Blood Glucose; Disease Models, Animal; Dyslipidemias; Emulsions; Fatty Acids, Nonesterified; Female; Glucose Clamp Technique; I-kappa B Kinase; I-kappa B Proteins; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Muscle, Skeletal; NF-KappaB Inhibitor alpha; Phospholipids; Phosphorylation; Rats, Wistar; Resveratrol; Serine; Soybean Oil; Stilbenes; Time Factors; Up-Regulation | 2015 |
Resveratrol relieves gestational diabetes mellitus in mice through activating AMPK.
Topics: Adenylate Kinase; Animals; Blood Glucose; Diabetes, Gestational; Female; Insulin Resistance; Mice; Pregnancy; Resveratrol; Signal Transduction; Stilbenes; Treatment Outcome | 2015 |
LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol.
Topics: Adipose Tissue; Animals; Antioxidants; Blood Glucose; Body Weight; Epididymis; Gene Expression Profiling; Glucose; Glucose Tolerance Test; Homeostasis; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Leukocytes; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Osmosis; Resveratrol; Stilbenes | 2016 |
Metformin and resveratrol ameliorate muscle insulin resistance through preventing lipolysis and inflammation in hypoxic adipose tissue.
Topics: 3T3-L1 Cells; Adipose Tissue; Administration, Oral; Animals; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Diet, High-Fat; Diglycerides; Fatty Acids; Feeding Behavior; Glucose; Hypoxia; Inflammation; Insulin; Insulin Resistance; Lipolysis; Male; Metformin; Mice; Mice, Inbred ICR; Models, Biological; Muscles; Resveratrol; Signal Transduction; Stilbenes | 2016 |
A mechanistic study to increase understanding of titanium dioxide nanoparticles-increased plasma glucose in mice.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Blood Glucose; Insulin Resistance; Male; Metal Nanoparticles; Mice; Reactive Oxygen Species; Resveratrol; Stilbenes; Titanium; Vitamin E | 2016 |
SILAC-MS Based Characterization of LPS and Resveratrol Induced Changes in Adipocyte Proteomics - Resveratrol as Ameliorating Factor on LPS Induced Changes.
Topics: Adipocytes; Adipose Tissue; Angiopoietin-Like Protein 3; Angiopoietin-like Proteins; Angiopoietins; Gastrointestinal Microbiome; Gene Expression Regulation; Glycosylation; Humans; Inflammation; Insulin; Insulin Resistance; Lipid Metabolism; Lipogenesis; Lipopolysaccharides; N-Acetylgalactosaminyltransferases; Obesity; Polypeptide N-acetylgalactosaminyltransferase; Proteome; Proteomics; Resveratrol; Stilbenes | 2016 |
Beneficial effects of combined resveratrol and metformin therapy in treating diet-induced insulin resistance.
Topics: Adiposity; Animals; Blood Glucose; Diet, High-Fat; Drug Therapy, Combination; Inflammation Mediators; Insulin Resistance; Male; Metformin; Mice; Mice, Inbred C57BL; Oncogene Protein v-akt; Organ Specificity; Resveratrol; Stilbenes | 2016 |
Long-term treatment with nicotinamide induces glucose intolerance and skeletal muscle lipotoxicity in normal chow-fed mice: compared to diet-induced obesity.
Topics: Animals; Antioxidants; Autophagy; Diet, High-Fat; Dietary Supplements; Gene Expression Regulation; Glucose Intolerance; Histone Deacetylase Inhibitors; Insulin Resistance; Lipid Metabolism; Male; Mice, Inbred C57BL; Mitophagy; Muscle Proteins; Muscle, Skeletal; Niacinamide; Obesity; Resveratrol; Sirtuin 1; Stilbenes; Time Factors | 2016 |
Sirtuin 1 and 7 mediate resveratrol-induced recovery from hyper-anxiety in high-fructose-fed prediabetic rats.
Topics: Animals; Antioxidants; Anxiety Disorders; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet; Epigenesis, Genetic; Fructose; Gene Expression Regulation; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Prediabetic State; Rats; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes | 2016 |
The role of expression imbalance between adipose synthesis and storage mediated by PPAR-γ/FSP27 in the formation of insulin resistance in catch up growth.
Topics: Adipocytes; Adipose Tissue; Animals; Apoptosis Regulatory Proteins; Caloric Restriction; Energy Intake; Epididymis; Epididymitis; Gene Expression Regulation; Humans; Insulin Resistance; Intra-Abdominal Fat; Male; Obesity; PPAR gamma; Proteins; Rats; Resveratrol; Stilbenes; Subcutaneous Fat | 2016 |
Plausible anti-inflammatory mechanism of resveratrol and caffeic acid against chronic stress-induced insulin resistance in mice.
Topics: Animals; Anti-Inflammatory Agents; Blood Glucose; Caffeic Acids; Corticosterone; Cytokines; Drug Therapy, Combination; Glyburide; Hypoglycemic Agents; Insulin Resistance; Male; Mice, Inbred Strains; Restraint, Physical; Resveratrol; Stilbenes; Stress, Psychological | 2016 |
SIRT1-AMPK crosstalk is involved in high glucose-dependent impairment of insulin responsiveness in primary rat podocytes.
Topics: AMP-Activated Protein Kinases; Animals; Glucose; Insulin; Insulin Resistance; Phosphorylation; Podocytes; Rats; Resveratrol; RNA, Small Interfering; Signal Transduction; Sirtuin 1; Stilbenes | 2016 |
Influence of resveratrol on endoplasmic reticulum stress and expression of adipokines in adipose tissues/adipocytes induced by high-calorie diet or palmitic acid.
Topics: 3T3-L1 Cells; Adipocytes; Adipokines; Adipose Tissue; Animals; Cell Differentiation; Endoplasmic Reticulum Stress; Insulin Resistance; Lipids; Male; Mice; Palmitic Acid; Resveratrol; Stilbenes | 2017 |
Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure.
Topics: Animals; Antioxidants; Energy Metabolism; Exercise Tolerance; Fatigue; Glucose; Heart Failure; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Microbiota; Muscle, Skeletal; Oxidation-Reduction; Oxygen Consumption; Physical Conditioning, Animal; Physical Exertion; Resveratrol; Stilbenes; Stroke Volume | 2017 |
Comparative effects of energy restriction and resveratrol intake on glycemic control improvement.
Topics: Adiponectin; Animals; Antioxidants; Blood Glucose; Caloric Restriction; Diet, High-Fat; Fructosamine; Gene Expression; Glucose Tolerance Test; Glucose Transporter Type 4; Insulin; Insulin Resistance; Leptin; Male; Muscle, Skeletal; Obesity; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Receptor, Insulin; Resveratrol; Stilbenes; Sucrose; Triglycerides | 2017 |
Comprehensive Metabolomic Analysis in Blood, Urine, Fat, and Muscle in Men with Metabolic Syndrome: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Resveratrol after Four Months' Treatment.
Topics: Adipose Tissue; Biomarkers; Blood Pressure; Gastrointestinal Microbiome; Humans; Insulin Resistance; Male; Metabolic Syndrome; Metabolomics; Middle Aged; Muscles; Obesity; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes | 2017 |
Resveratrol ameliorates the chemical and microbial induction of inflammation and insulin resistance in human placenta, adipose tissue and skeletal muscle.
Topics: Adipose Tissue; Diabetes, Gestational; Female; Humans; Infant; Inflammation; Insulin; Insulin Resistance; Muscle, Skeletal; Placenta; Pregnancy; Resveratrol; Signal Transduction; Stilbenes | 2017 |
[Resveratrol improves high-fat induced nonalcoholic fatty liver in rats].
Topics: AMP-Activated Protein Kinases; Animals; Fatty Liver; Insulin Resistance; Male; Phytotherapy; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2008 |
Conjugated linoleic acid-mediated inflammation and insulin resistance in human adipocytes are attenuated by resveratrol.
Topics: Adipocytes; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Fatty Acids; Humans; Inflammation Mediators; Insulin Resistance; Linoleic Acids, Conjugated; Middle Aged; PPAR gamma; Resveratrol; Stilbenes; Transfection; Triglycerides | 2009 |
AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol.
Topics: AMP-Activated Protein Kinases; Animals; Cells, Cultured; Drug Resistance; Enzyme Inhibitors; Fibroblasts; Glucose Intolerance; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mitochondria; Muscle, Skeletal; NAD; Resveratrol; Sirtuin 1; Stilbenes; Weight Loss | 2010 |
Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms.
Topics: Angiogenesis Inhibitors; Atherosclerosis; Carotid Arteries; Down-Regulation; Glucose; Glucose Tolerance Test; Humans; Insulin Resistance; Longevity; Metabolic Syndrome; Monocytes; Palmitic Acid; Reference Values; Resveratrol; Sirtuin 1; Stilbenes; Tunica Intima; Tunica Media | 2010 |
Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: Relative to inhibition of inflammatory responses.
Topics: 3T3-L1 Cells; Adipocytes; Adipokines; Animals; Anti-Inflammatory Agents; Culture Media, Conditioned; Gene Expression Regulation; Glucose; Inflammation; Insulin; Insulin Resistance; Interleukin-6; Lipopolysaccharides; Macrophages; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Phosphorylation; Resveratrol; RNA, Messenger; Signal Transduction; Stilbenes; Tumor Necrosis Factor-alpha | 2010 |
SIRT1 takes a backseat to AMPK in the regulation of insulin sensitivity by resveratrol.
Topics: AMP-Activated Protein Kinases; Animals; Cardiovascular Diseases; Enzyme Inhibitors; Humans; Insulin Resistance; Obesity; Resveratrol; Sirtuin 1; Stilbenes | 2010 |
Resveratrol reduces lipid peroxidation and increases sirtuin 1 expression in adult animals programmed by neonatal protein restriction.
Topics: Animals; Animals, Newborn; Antioxidants; Blood Glucose; Diet, Protein-Restricted; Female; Insulin; Insulin Resistance; Lipid Peroxidation; Lipids; Liver; Male; Rats; Rats, Wistar; Resveratrol; Sirtuin 1; Stilbenes; Superoxide Dismutase | 2010 |
Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated inflammation and insulin resistance in primary human adipocytes.
Topics: Adipocytes; Adult; Anti-Inflammatory Agents; Female; Gene Expression; Glucose; Humans; Inflammation; Insulin; Insulin Resistance; Middle Aged; Phosphorylation; Phytotherapy; Plant Extracts; PPAR gamma; Quercetin; Resveratrol; Signal Transduction; Stilbenes; Transcription, Genetic; Tumor Necrosis Factor-alpha; Vitis; Young Adult | 2010 |
Effects of resveratrol on NO secretion stimulated by insulin and its dependence on SIRT1 in high glucose cultured endothelial cells.
Topics: Antioxidants; E-Selectin; Endothelial Cells; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Nitric Oxide; Nitric Oxide Synthase Type III; Resveratrol; RNA, Messenger; RNA, Small Interfering; Sirtuin 1; Stilbenes; Umbilical Veins | 2010 |
Resveratrol improves insulin resistance hyperglycemia and hepatosteatosis but not hypertriglyceridemia, inflammation, and life span in a mouse model for Werner syndrome.
Topics: Animals; Anticarcinogenic Agents; Disease Models, Animal; Fatty Liver; Hyperglycemia; Hypertriglyceridemia; Inflammation; Insulin Resistance; Mice; Mice, Inbred C57BL; Resveratrol; Stilbenes; Werner Syndrome | 2011 |
Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1.
Topics: Adult; Animals; Animals, Genetically Modified; Caenorhabditis elegans; Case-Control Studies; Cell Line; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Longevity; Middle Aged; Muscle Fibers, Skeletal; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Binding; Recombinant Fusion Proteins; Resveratrol; RNA Interference; Signal Transduction; Sirtuin 1; Stilbenes; Tumor Necrosis Factor-alpha | 2011 |
Resveratrol attenuates high-fat diet-induced insulin resistance by influencing skeletal muscle lipid transport and subsarcolemmal mitochondrial β-oxidation.
Topics: Animals; Biological Transport; Diet, High-Fat; Down-Regulation; Insulin Resistance; Lipid Metabolism; Male; Mitochondria, Muscle; Muscle, Skeletal; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Resveratrol; Sarcolemma; Stilbenes | 2011 |
Resveratrol may be beneficial in treatment of diabetic foot syndrome.
Topics: Diabetic Foot; Dietary Supplements; Humans; Insulin Resistance; Resveratrol; Signal Transduction; Sirtuin 1; Sirtuins; Stilbenes; Wound Healing | 2011 |
Resveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the rat.
Topics: Adipose Tissue; Animals; Biological Availability; Biomarkers; Body Temperature Regulation; Bone Density; Enzyme Inhibitors; Glucose Tolerance Test; Hindlimb Suspension; Inflammation; Insulin Resistance; Male; Muscle, Skeletal; Muscular Atrophy; Physical Conditioning, Animal; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2011 |
High dose of dietary resveratrol enhances insulin sensitivity in healthy rats but does not lead to metabolite concentrations effective for SIRT1 expression.
Topics: Animals; Blood Glucose; Cholesterol; Fatty Acids, Nonesterified; Female; Glycated Hemoglobin; Hep G2 Cells; Humans; Insulin; Insulin Resistance; Liver; Male; Rats; Rats, Wistar; Resveratrol; RNA, Messenger; Sirtuin 1; Stilbenes; Triglycerides | 2011 |
Improving glucose metabolism with resveratrol in a swine model of metabolic syndrome through alteration of signaling pathways in the liver and skeletal muscle.
Topics: Animals; Blood Glucose; Case-Control Studies; Dietary Carbohydrates; Energy Intake; Energy Metabolism; Insulin; Insulin Resistance; Liver; Liver Function Tests; Metabolic Syndrome; Microscopy, Fluorescence; Muscle, Skeletal; Phytotherapy; Plant Extracts; Resveratrol; Signal Transduction; Stilbenes; Swine; Swine, Miniature; Treatment Outcome | 2011 |
Continued postnatal administration of resveratrol prevents diet-induced metabolic syndrome in rat offspring born growth restricted.
Topics: Animals; Antioxidants; Body Weight; Calorimetry, Indirect; Dietary Fats; Energy Intake; Female; Fetal Growth Retardation; Hypoxia; Insulin Resistance; Male; Metabolic Syndrome; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Resveratrol; Stilbenes | 2011 |
Mediobasal hypothalamic SIRT1 is essential for resveratrol's effects on insulin action in rats.
Topics: Animals; Enzyme Activators; Enzyme Inhibitors; Gene Silencing; Glucose; Hypoglycemic Agents; Hypothalamus, Middle; Insulin; Insulin Antagonists; Insulin Resistance; KATP Channels; Liver; Male; Organ Specificity; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Small Interfering; Sirtuin 1; Stilbenes | 2011 |
Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents.
Topics: 3T3-L1 Cells; Adipocytes; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Blotting, Western; Cells, Cultured; Culture Media, Conditioned; Dietary Fats; Inflammation; Insulin; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Phosphorylation; Real-Time Polymerase Chain Reaction; Resveratrol; Signal Transduction; Stilbenes | 2012 |
Resveratrol: is selectivity opening the key to therapeutic effects?
Topics: Animals; Anti-Inflammatory Agents; Insulin; Insulin Resistance; Male; Resveratrol; Signal Transduction; Stilbenes | 2012 |
Resveratrol improves insulin resistance of catch-up growth by increasing mitochondrial complexes and antioxidant function in skeletal muscle.
Topics: Animals; Antioxidants; Caloric Restriction; Citrate (si)-Synthase; Glucose; Insulin Resistance; Male; Mitochondria, Muscle; Muscle, Skeletal; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Refeeding Syndrome; Resveratrol; Stilbenes | 2012 |
Effects of resveratrol on the amelioration of insulin resistance in KKAy mice.
Topics: Adiponectin; Adipose Tissue; AMP-Activated Protein Kinases; Animals; Blood Glucose; Disease Models, Animal; Glucose Metabolism Disorders; Glucose Tolerance Test; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Phosphorylation; Proto-Oncogene Proteins c-akt; Resveratrol; RNA, Messenger; Sirtuin 1; Stilbenes; Time Factors | 2012 |
Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet.
Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diet, High-Fat; Fatty Liver; Glucose Tolerance Test; Inflammation; Insulin Resistance; Male; Maze Learning; Memory Disorders; Mice; Obesity; Resveratrol; Stilbenes | 2012 |
The polyphenols resveratrol and S17834 prevent the structural and functional sequelae of diet-induced metabolic heart disease in mice.
Topics: Adiponectin; Animals; Antihypertensive Agents; Benzopyrans; Diastole; Diet, High-Fat; Dietary Carbohydrates; Hypertrophy, Left Ventricular; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Protein Processing, Post-Translational; Resveratrol; Stilbenes; Ventricular Function, Left | 2012 |
Effects of chronic calorie restriction or dietary resveratrol supplementation on insulin sensitivity markers in a primate, Microcebus murinus.
Topics: Animal Feed; Animals; Blood Glucose; Caloric Restriction; Diet; Dietary Supplements; Glucose Tolerance Test; Insulin; Insulin Resistance; Lemur; Male; Oxygen Consumption; Resveratrol; Stilbenes; Time Factors | 2012 |
SIRT1 attenuates palmitate-induced endoplasmic reticulum stress and insulin resistance in HepG2 cells via induction of oxygen-regulated protein 150.
Topics: Endoplasmic Reticulum Stress; Forkhead Box Protein O1; Forkhead Transcription Factors; Hep G2 Cells; HSP70 Heat-Shock Proteins; Humans; Insulin Resistance; Palmitates; Proteins; Resveratrol; Sirtuin 1; Stilbenes | 2012 |
Caveolin-3 is involved in the protection of resveratrol against high-fat-diet-induced insulin resistance by promoting GLUT4 translocation to the plasma membrane in skeletal muscle of ovariectomized rats.
Topics: Animals; Caveolin 3; Cell Membrane; Diet, High-Fat; Estrogen Receptor alpha; Female; Glucose; Glucose Intolerance; Glucose Transporter Type 4; Insulin; Insulin Resistance; Muscle Fibers, Skeletal; Muscle, Skeletal; Ovariectomy; Protective Agents; Protein Transport; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2012 |
Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats.
Topics: Animals; Ascorbic Acid; Blood Glucose; Body Weight; Catalase; Eating; Fructose; Glucose Tolerance Test; Glutathione; Insulin; Insulin Resistance; Liver; Male; Metabolic Syndrome; Metformin; NF-E2-Related Factor 2; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Triglycerides; Uric Acid | 2012 |
Muscle mitochondria and insulin resistance: a human perspective.
Topics: Animals; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Mitochondria, Muscle; Resveratrol; Stilbenes | 2012 |
Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ.
Topics: 3T3 Cells; Acetylation; Adipose Tissue, Brown; Adipose Tissue, White; Adult; Amino Acid Sequence; Animals; Cells, Cultured; Energy Metabolism; Female; Humans; Insulin Resistance; Ligands; Lysine; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Obesity; PPAR gamma; Resveratrol; Sequence Alignment; Sirtuin 1; Stilbenes; Thermogenesis; Thiazolidinediones | 2012 |
Acute exposure to resveratrol inhibits AMPK activity in human skeletal muscle cells.
Topics: AMP-Activated Protein Kinases; Cell Differentiation; Diabetes Mellitus, Type 2; Drug Interactions; Enzyme Inhibitors; Glucose; Glycogen; Humans; Insulin Resistance; Male; Middle Aged; Muscle Fibers, Skeletal; Palmitates; Phosphorylation; Primary Cell Culture; Resveratrol; Signal Transduction; Stilbenes | 2012 |
Resveratrol upregulates Nrf2 expression to attenuate methylglyoxal-induced insulin resistance in Hep G2 cells.
Topics: Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Heme Oxygenase-1; Hep G2 Cells; Humans; Hyperglycemia; Insulin Resistance; NF-E2-Related Factor 2; Pyruvaldehyde; Resveratrol; Stilbenes; Up-Regulation | 2012 |
Vodka and wine consumption in a swine model of metabolic syndrome alters insulin signaling pathways in the liver and skeletal muscle.
Topics: Alcohol Drinking; Alcoholic Beverages; Animals; Blood Glucose; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Glucose Transporter Type 4; Immunohistochemistry; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Liver Function Tests; Male; Metabolic Syndrome; Muscle, Skeletal; PPAR alpha; Resveratrol; Stilbenes; Swine; Up-Regulation | 2012 |
Resveratrol attenuates oxidative stress and prevents steatosis and hypertension in obese rats programmed by early weaning.
Topics: Animals; Antioxidants; Blood Glucose; Dyslipidemias; Fatty Liver; Female; Glutathione Peroxidase; Hyperphagia; Hypertension; Insulin Resistance; Liver; Obesity; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Weaning | 2013 |
Chronic resveratrol treatment protects pancreatic islets against oxidative stress in db/db mice.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Blood Glucose; Deoxyguanosine; Diabetes Mellitus, Type 2; Disease Models, Animal; Fibrosis; Glucose Tolerance Test; Immunohistochemistry; Insulin; Insulin Resistance; Islets of Langerhans; Male; Mice; Organ Size; Oxidative Stress; Resveratrol; Stilbenes | 2012 |
Resveratrol potentiates rapamycin to prevent hyperinsulinemia and obesity in male mice on high fat diet.
Topics: Animals; Cell Line, Tumor; Cellular Senescence; Diet, High-Fat; Humans; Hyperinsulinism; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin; Insulin Resistance; Male; Mice; Obesity; Resveratrol; Sirolimus; Stilbenes; TOR Serine-Threonine Kinases; Transcription, Genetic; Weight Gain | 2013 |
Potential utility of natural polyphenols for reversing fat-induced insulin resistance.
Topics: Adipocytes; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Flavonoids; Humans; I-kappa B Kinase; Insulin Resistance; Models, Biological; Phenols; Polyphenols; Probenecid; Protein Serine-Threonine Kinases; Resveratrol; Silybin; Silymarin; Stilbenes | 2005 |
Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats.
Topics: Administration, Oral; Animal Feed; Animals; Antioxidants; Arteriosclerosis; Biomarkers; Blood Pressure; Follow-Up Studies; Fructose; Heart Ventricles; Hypertension; Insulin Resistance; Lipid Peroxidation; Male; Mesenteric Arteries; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Resveratrol; Risk Factors; Spectrophotometry; Stilbenes; Sweetening Agents; Thiobarbituric Acid Reactive Substances; Time Factors | 2005 |
Medicine: grapes versus gluttony.
Topics: Animals; Caloric Restriction; Energy Intake; Health; Humans; Insulin Resistance; Longevity; Mice; Obesity; Resveratrol; Stilbenes | 2006 |
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha.
Topics: Acetylation; Adult; Animals; Dietary Fats; Energy Metabolism; Gene Expression Regulation; Humans; Insulin Resistance; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mitochondria, Muscle; Motor Activity; Muscle Fibers, Skeletal; Obesity; Oxidative Phosphorylation; Oxygen Consumption; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Polymorphism, Single Nucleotide; Resveratrol; Sirtuin 1; Sirtuins; Specific Pathogen-Free Organisms; Stilbenes; Trans-Activators; Transcription Factors | 2006 |
[Cheers !].
Topics: Acetylation; Animals; Antioxidants; Caloric Restriction; Heat-Shock Proteins; Humans; Insulin Resistance; Longevity; Mice; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Protein Processing, Post-Translational; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes; Trans-Activators; Transcription Factors; Wine | 2007 |
SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B.
Topics: Animals; Chromatin; Down-Regulation; Gene Expression Regulation; Insulin; Insulin Resistance; Mice; Mice, Knockout; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Resveratrol; RNA, Small Interfering; Sirtuin 1; Sirtuins; Stilbenes | 2007 |